Biogen Surges After FDA Reviewers Support Alzheimer’s Drug

(Bloomberg) -- Biogen Inc.’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according to a report by staff of the U.S. Food and Drug Administ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.